Miss Zoya Kikhtyak

Adelaide Medical School

Faculty of Health and Medical Sciences


Year Citation
2024 Hosseinzadeh, L., Kikhtyak, Z., Laven-Law, G., Pederson, S. M., Puiu, C. G., D'Santos, C. S., . . . Hickey, T. E. (2024). The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer. Genome Biol, 25(1), 44-1-44-28.
DOI Scopus16 WoS15 Europe PMC14
2023 Horsfall, A. J., Chav, T., Pederick, J. L., Kikhtyak, Z., Vandborg, B. C., Kowalczyk, W., . . . Bruning, J. B. (2023). Designing Fluorescent Nuclear Permeable Peptidomimetics to Target Proliferating Cell Nuclear Antigen. Journal of Medicinal Chemistry, 66(15), 10354-10363.
DOI Scopus1 WoS1 Europe PMC1
2023 Mustafa, E. H., Laven-Law, G., Kikhtyak, Z., Nguyen, V., Ali, S., Pace, A. A., . . . Hickey, T. E. (2023). Selective inhibition of CDK9 in triple negative breast cancer. Oncogene, 43(3), 202-215.
DOI Scopus13 WoS13 Europe PMC9
2022 Kumar, R., Corbett, M. A., Smith, N. J. C., Hock, D. H., Kikhtyak, Z., Semcesen, L. N., . . . Gecz, J. (2022). Oligonucleotide correction of an intronic TIMMDC1 variant in cells of patients with severe neurodegenerative disorder. npj Genomic Medicine, 7(1), 9-1-9-12.
DOI Scopus14 WoS11 Europe PMC16
2021 Horsfall, A. J., Vandborg, B., Kikhtyak, Z., Scanlon, D. B., Tilley, W. D., Hickey, T. E., . . . Abell, A. D. (2021). A cell permeable bimane-constrained PCNA-interacting peptide. RSC Chemical Biology, 2(5), 1499-1508.
DOI Scopus5 WoS5 Europe PMC3
2021 Valdés-Mora, F., Salomon, R., Gloss, B. S., Law, A. M. K., Venhuizen, J., Castillo, L., . . . Gallego-Ortega, D. (2021). Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype. Cell Reports, 35(2), 25 pages.
DOI Scopus41 WoS39 Europe PMC49
2017 Oakes, S. R., Gallego-Ortega, D., Stanford, P. M., Junankar, S., Au, W. W. Y., Kikhtyak, Z., . . . Ormandy, C. J. (2017). A mutation in the viral sensor 2’-5’-oligoadenylate synthetase 2 causes failure of lactation. PLoS Genetics, 13(11), e1007072-1-e1007072-24.
DOI Scopus14 WoS15 Europe PMC18
2015 Gallego-Ortega, D., Ledger, A., Roden, D. L., Law, A. M. K., Magenau, A., Kikhtyak, Z., . . . Ormandy, C. J. (2015). ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells. Plos Biology, 13(12), 27 pages.
DOI Scopus56 WoS54 Europe PMC56

Year Citation
2025 Mustafa, E., Laven-Law, G., Winter, J., Kikhtyak, Z., Bergeron, A., MacGrogan, G., . . . Hickey, T. (2025). The transcription factor AP-2β defines active enhancers conferring molecular apocrine cell identity in breast cancer.
DOI
2019 Valdes-Mora, F., Salomon, R., Gloss, B., Law, A. M. K., Castillo, L., Murphy, K., . . . Gallego-Ortega, D. (2019). Single cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype.
DOI

Connect With Me

External Profiles

Other Links